This is an Expression of Interest page. By clicking “Register Now” your name will be added to a wait list. You will be notified to register via email when a session becomes available in your state of residence or practice.
From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.